A Randomized Controlled Trial of Fludrocortisone for the Treatment of Hyperkalemia in Hemodialysis Patients

American Journal of Kidney Diseases

Volumn 47, Issue 5, 2006, Pages 809-814

  Kaisar, Mohammed O ^a   Wiggins, Kathryn J ^a   Sturtevant, Joanne M ^a   Hawley, Carmel M ^a   Campbell, Scott B ^a   Isbel, Nicole M ^a   Mudge, David W ^a   Bofinger, Andrew ^a   Petrie, James J B ^a   Johnson, David W ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

chronic kidney failure; Dialysis; fludrocortisone acetate; potassium

Indexed keywords

FLUDROCORTISONE; POTASSIUM;

ANALYSIS OF VARIANCE; ARTICLE; CALCULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIALYSIS; DRUG EFFECT; DRUG SAFETY; DRUG SCREENING; DRUG TOLERABILITY; FEMALE; HEMODIALYSIS; HOSPITALIZATION; HUMAN; HYPERKALEMIA; MAJOR CLINICAL STUDY; MALE; POTASSIUM BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; UNSPECIFIED SIDE EFFECT;

ADMINISTRATION, ORAL; FEMALE; FLUDROCORTISONE; HUMANS; HYPERKALEMIA; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; POTASSIUM; PROSPECTIVE STUDIES; RENAL DIALYSIS;

EID: 33646036682     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2006.01.014     Document Type: Article

References (10)

1. Tzamaloukas A.H., and Avasthi P.S. Temporal profile of serum potassium concentration in nondiabetic and diabetic outpatients on chronic dialysis. Am J Nephrol 7 (1987) 101-109
2. Imbriano L.J., Durham J.H., and Maesaka J.K. Treating interdialytic hyperkalemia with fludrocortisone. Semin Dial 16 (2003) 5-7
3. Blumberg A., Weidmann P., Shaw S., and Gnadinger M. Effect of various therapeutic approaches on plasma potassium and major regulating factors in terminal renal failure. Am J Med 85 (1988) 507-512
4. Morrison G., Michelson E.L., Brown S., and Morganroth J. Mechanism and prevention of cardiac arrhythmias in chronic hemodialysis patients. Kidney Int 17 (1980) 811-819
5. Hou S., McElroy P.A., Nootens J., and Beach M. Safety and efficacy of low-potassium dialysate. Am J Kidney Dis 13 (1989) 137-143
6. Karnik J.A., Young B.S., Lew N.L., et al. Cardiac arrest and sudden death in dialysis units. Kidney Int 60 (2001) 350-357
7. Scott T.R., Graham S.M., Schweitzer E.J., and Bartlett S.T. Colonic necrosis following sodium polystyrene sulfonate (Kayexalate)-sorbitol enema in a renal transplant patient. Report of a case and review of the literature. Dis Colon Rectum 36 (1993) 607-609
8. Nyman N., Mulgaonkar S., Walcer R., Viscuso R., and Jacobs M.G. Effects of a mineralocorticoid on extra-renal potassium homeostasis in anuric patients. Kidney Int 23 (1983) 155A (abstr)
9. Singhal P.C., Desroches L., Mattana J., Abramovici M., Wagner J.D., and Maesaka J.K. Mineralocorticoid therapy lowers serum potassium in patients with end-stage renal disease. Am J Nephrol 13 (1993) 138-141
10. Furuya R., Kumagai H., Sakao T., Maruyama Y., and Hishida A. Potassium-lowering effect of mineralocorticoid therapy in patients undergoing hemodialysis. Nephron 92 (2002) 576-581